NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 6.671
EU - Europa 4.493
AS - Asia 3.605
SA - Sud America 420
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
Totale 15.275
Nazione #
US - Stati Uniti d'America 6.554
IT - Italia 1.661
GB - Regno Unito 1.119
CN - Cina 1.105
SG - Singapore 1.067
SE - Svezia 450
HK - Hong Kong 380
VN - Vietnam 344
BR - Brasile 314
DE - Germania 297
TR - Turchia 229
UA - Ucraina 188
FI - Finlandia 179
FR - Francia 152
RU - Federazione Russa 124
KR - Corea 118
IN - India 95
BG - Bulgaria 64
NL - Olanda 64
CA - Canada 55
AR - Argentina 44
BD - Bangladesh 42
MX - Messico 41
ID - Indonesia 34
PL - Polonia 28
IQ - Iraq 27
IE - Irlanda 23
ES - Italia 21
IR - Iran 21
LT - Lituania 20
IL - Israele 18
PK - Pakistan 18
BE - Belgio 17
ZA - Sudafrica 17
CO - Colombia 15
JP - Giappone 15
SA - Arabia Saudita 14
AT - Austria 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
EU - Europa 12
SI - Slovenia 11
CL - Cile 10
EC - Ecuador 10
EG - Egitto 9
MA - Marocco 9
DZ - Algeria 8
MY - Malesia 8
TH - Thailandia 8
VE - Venezuela 8
JO - Giordania 7
UZ - Uzbekistan 7
BY - Bielorussia 6
DK - Danimarca 6
PY - Paraguay 6
CZ - Repubblica Ceca 5
GR - Grecia 5
KE - Kenya 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
UY - Uruguay 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
PA - Panama 4
RO - Romania 4
TN - Tunisia 4
AU - Australia 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
NG - Nigeria 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
KG - Kirghizistan 2
LV - Lettonia 2
MG - Madagascar 2
MK - Macedonia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
Totale 15.262
Città #
Southend 832
Santa Clara 809
Singapore 724
Ashburn 572
Woodbridge 496
Fairfield 433
Chandler 429
Hong Kong 371
Jacksonville 354
Hefei 332
Houston 263
Ann Arbor 260
Nyköping 246
Beijing 240
Dearborn 234
San Jose 197
Wilmington 197
Seattle 172
London 157
Cambridge 150
Rome 144
Milan 134
Dallas 133
Izmir 120
Seoul 116
Helsinki 114
Los Angeles 110
Ho Chi Minh City 89
The Dalles 87
Hanoi 77
New York 70
Princeton 70
Naples 69
Buffalo 63
San Diego 62
Sofia 62
Eugene 61
Chicago 58
Frankfurt am Main 57
Council Bluffs 55
Lauterbourg 54
Modena 54
Shanghai 51
Des Moines 38
Moscow 37
Munich 36
São Paulo 36
Bologna 34
Bari 32
Florence 30
Palermo 29
Da Nang 24
Orem 24
Chennai 23
Philadelphia 23
Guangzhou 21
Turin 21
Dublin 20
Brescia 19
Catania 18
Mexico City 17
Brussels 16
Columbus 16
Elk Grove Village 16
Haiphong 16
Redwood City 16
Salt Lake City 16
San Mateo 15
Atlanta 14
Augusta 14
Phoenix 14
Vancouver 14
Warsaw 14
Amsterdam 13
Baghdad 13
Boardman 13
Falkenstein 13
Jakarta 13
Rio de Janeiro 13
Stockholm 13
Nanjing 12
Norwalk 12
Tampa 12
Brooklyn 11
Kent 11
Montreal 11
Mumbai 11
Parma 11
Tokyo 11
Toronto 11
Falls Church 10
Johannesburg 10
Kunming 10
Mashhad 10
Ottawa 10
Verona 10
Bremen 9
Changsha 9
Denver 9
Grafing 9
Totale 10.341
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.711
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 352
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 308
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 307
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 303
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 296
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 283
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 279
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 278
Detectable HIV viral load is associated with metabolic syndrome 276
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 273
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 268
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 267
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 265
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 265
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 264
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 259
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 252
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 252
Age-related comorbidities in people living with HIV 249
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 247
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 246
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 230
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 229
Severity of lipodystrophy is associated with decreased health-related quality of life 229
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 223
Does lipodistrophy affect quality of life? 221
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 220
Body Image perception in HIV infected women with body fat redistribution. 216
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 214
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 213
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 211
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 210
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 204
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 203
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 203
How do frailty mediate pathway leading to disability 198
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 194
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 193
È possibile un counselling HIV su internet? 193
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 191
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 190
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 188
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 187
Virologic failure and metabolic syndrome in patients with HIV infection 185
Validity of body image perception in women with HIV. 184
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 181
Virologic failure and metabolic syndrome in patients with HIV infection 181
Relapse of HIV-related buffalo hump after liposuction 172
Prevalence and risk factors of pubic lipomas in HIV-infected patients 171
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 171
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 170
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 167
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 165
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 162
Qual è il rapporto tra qualità di vita e lipodistrofia 160
HIV counselling looks for new target and methods web versus face to face counselling 159
Lipodystrophy and quality of life: a prospective study 157
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 154
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 146
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 136
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 135
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 133
HIV counselling and prevention on the WEB 128
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 119
Totale 15.396
Categoria #
all - tutte 49.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021276 0 0 0 0 0 0 0 0 0 118 95 63
2021/2022987 21 158 63 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20252.944 117 69 73 227 624 427 221 127 337 97 294 331
2025/20264.331 335 235 509 561 579 402 507 273 544 386 0 0
Totale 15.396